BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.65 0.0  0.0%

Last Trade - 7:13pm

Sector
Healthcare
Size
Small Cap
Market Cap £254.5m
Enterprise Value £227.7m
Revenue £112.6m
Position in Universe 3926th / 6846

BRIEF-BioDelivery Sciences Reacquires Onsolis From Collegium Pharmaceutical

Thu 14th December, 2017 9:30pm
Dec 14 (Reuters) - BioDelivery Sciences International Inc 
 BDSI.O : 
    * BIODELIVERY SCIENCES REACQUIRES ONSOLIS FROM COLLEGIUM 
PHARMACEUTICAL 
    * BIODELIVERY SCIENCES - GOT 90-DAY NOTICE FROM COLLEGIUM 
REGARDING TERMINATION OF LICENSE AND DEVELOPMENT AGREEMENT FOR 
ONSOLIS 
    * BIODELIVERY SCIENCES INTERNATIONAL - TERMINATION OF 
AGREEMENT 
WILL BE EFFECTIVE ON MARCH 8, 2018 
    * BIODELIVERY SCIENCES - COLLEGIUM TO TERMINATE LICENSE DUE 
TO ITS 
AGREEMENT TO COMMERCIALIZE NUCYNTA IMMEDIATE RELEASE, NUCYNTA ER 
    * BIODELIVERY SCIENCES - "WE WILL BE ASSESSING OPTIONS FOR 
COMMERCIALIZING ONSOLIS" 
    * BIODELIVERY SCIENCES - DO NOT CURRENTLY BELIEVE RETURN OF 
ONSOLIS TO US WILL HAVE MATERIAL IMPACT ON BUSINESS 
 
Source text for Eikon:  ID:nGNXOJZNMa  
Further company coverage:  BDSI.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.